PHARMACEUTICAL COMPOSITION

플루티카손 및 시클레소니드로부터 선택된 코르티코스테로이드와 조합된, 인다카테롤 및 포르모테롤로부터 선택된 베타-효능제를 포함하고, 선택적으로 1종 이상의 약학적으로 허용가능한 첨가제를 포함하는 약학 조성물. Described herein is a pharmaceutical composition that includes a beta2-agonist selected from indacaterol and formoterol in combination with a corticosteroid selected from fluticasone a...

Full description

Saved in:
Bibliographic Details
Main Authors PURANDARE SHRINIVAS MADHUKAR, MALHOTRA GEENA
Format Patent
LanguageEnglish
Korean
Published 16.03.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:플루티카손 및 시클레소니드로부터 선택된 코르티코스테로이드와 조합된, 인다카테롤 및 포르모테롤로부터 선택된 베타-효능제를 포함하고, 선택적으로 1종 이상의 약학적으로 허용가능한 첨가제를 포함하는 약학 조성물. Described herein is a pharmaceutical composition that includes a beta2-agonist selected from indacaterol and formoterol in combination with a corticosteroid selected from fluticasone and ciclesonide, and, optionally, one or more pharmaceutically acceptable excipients.
Bibliography:Application Number: KR20187006863